Development of a second generation Inhibin B ELISA

Journal of Immunological Methods

Volumn 362, Issue 1-2, 2010, Pages 22-31

  Kalra, Bhanu ^a   Kumar, Ajay ^a   Patel, Kinita ^a   Patel, Amita ^a   Khosravi, M J ^b  

^a Beckman Coulter Inc   (United States)

^b BECKMAN COULTER INC   (United States)

Author keywords

ART; Assisted reproductive technologies (ART); Fetal bovine serum (FBS); Follicle stimulating hormone (FSH); Gametogenesis; In vitro fertilization (IVF); Infertility; Inhibin B; IVF; Limit of detection (LoD); Limit of quantitation (LoQ); Ovarian hyperstimulation syndrome (OHSS); Ovarian reserve

Indexed keywords

ACTIVIN; ACTIVIN A; ACTIVIN AB; AMH PROTEIN; FOLLISTATIN; FOLLITROPIN; INHIBIN A; INHIBIN B; LUTEINIZING HORMONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY R1; MYELOPID; PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; ARTICLE; CALIBRATION; CALIBRATOR; CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NONHUMAN; NORMAL HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN STABILITY; RAT; REPRODUCIBILITY; RHESUS MONKEY; SENSITIVITY AND SPECIFICITY;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOSA CELLS; HUMANS; INHIBINS; MALE; MIDDLE AGED; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SERTOLI CELLS;

BOVINAE;

EID: 77958507048     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.08.002     Document Type: Article

References (33)

1. Anawalt B.D., Bebb R.A., Matsumoto A.M., Groome N.P., Illingworth P.J., McNeilly A.S., Bremner W.J. Serum Inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J. Clin. Endocrinol. Metab. 1996, 81(9):3341.
2. Attardi B., Vaughan J., Vale W. Regulation of FSH beta messenger ribonucleic acid levels in the rat by endogenous inhibin. Endocrinology 1992, 130:557.
3. Ballesca J.L., Balasch J., Calafell J.M., Alvarez R., Fabregues F., de Osaba M.J., Ascaso C., Vanrell J.A. Serum Inhibin determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia. Hum. Reprod. 2000, 15(8):1734.
4. Burger H.G., Igarashi M. Inhibin: definition and nomenclature, including related substances. J. Clin. Endocrinol. Metab. 1988, 66:885.
5. Burger H.G., Groome N.P., Robertson D.M. Both Inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle. J. Clin. Endocrinol. Metab. 1998, 83:4167.
6. Chen C.L. Inhibin and activin as paracrine/autocrine factors. Endocrinol. 1993, 132:4.
7. Conway G.S. Premature ovarian failure. Curr. Opin. Obstet. Gynaecol. 1997, 9:202.
8. Evans L.W., Groome N.P. Development of immunoassays for inhibin, activin and follistatin. Inhibin, Activin and Follistatin in Human Reproductive Physiology 2001, 11. Imperial College Press, London. S. Muttukrishna, W. Ledger (Eds.).
9. Fawzy M., Lambert A., Harrison R.F., Knight P.G., Groome N., Hennelly B., Robertson W.R. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. Hum. Reprod. 2002, 17(6):1535.
10. Groome N., Hancock J., Betteridge A., Lawrence M., Carven R. Monoclonal and polyclonal antibodies reactive with the 1-32 aminoterminal sequence of the alpha subunit of human 32K inhibin. Hybridoma 1990, 9:31.
11. Groome N.P., Illingworth P.J., O'Brien M., Pai R., Rodger F.E., Mather J.P., McNeilly A.S. Measurement of dimeric inhibin B in the human menstrual cycle using a new ultrasensitive ELISA. J. Clin. Endocrinol. Metab. 1996, 81:1401-1405.
12. Harlow E., Lane D. Immunoaffinity purification. Antibodies: a Laboratory Manual 1988, 511. Cold Spring Harbour Laboratory Press, New York.
13. Knight P.G., Glister C. Potential local regulatory function of Inhibins, activins and follistatin in the ovary. Reproduction 2001, 121:503.
14. Kricka L.J. Human anti-animal antibody interference in immunological assay. Clin. Chem. 1999, 45:942.
15. Kumanov P., Nandipati K., Tomova A., Agrawal A. Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility. Fertil. Steril. 2006, 86(2):332.
16. Ludlow H., Muttukrishna S., Hyvonen M., Groome N.P. Development of a new antibody to the human inhibin/activin βB subunit and its application to improved Inhibin B ELISAs. J. Immunol. Methods 2008, 329(1-2):102.
17. Mason A.J., Niall H.D., Seeburg P.H. Structure of two human ovarian Inhibins. Biochem. Biophys. Res. Commun. 1986, 135:957.
18. Miyamoto K., Hasegawa Y., Fukuda M., Nomura M., Igarashi M., Kangawa K., Matuso H. Isolation of porcine follicular fluid inhibin of 32K Daltons. Biochem. Biophys. Res. Commun. 1985, 129:396.
19. Muttukrishna S., McGarrigle H., Wakim R., Khadum I., Ranieri D.M., Serhal P. Antral follicle count, anti mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. BJOG 2005, 112(10):1384.
20. National Committee for Clinical Laboratory Standards Evaluation of the Linearity of Quantitative Analytical Methods; Proposed Guideline EP-6 1986, NCCLS, Wayne, PA.
21. National Committee for Clinical Laboratory Standards Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline EP9-A 1995, NCCLS, Wayne, PA.
22. National Committee for Clinical Laboratory Standards Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline EP5-A 1999, NCCLS, Wayne, PA.
23. National Committee for Clinical Laboratory Standards Protocol for determination of limits of detection and limits of quantitation; Approved Guideline EP17-A, 664, V0l 24 No 34 2004, NCCLS, Wayne, PA.
24. Pierik F.H., Vreeburg J.T., Stijnen T., Jong De F.H., Weber R.F. Serum inhibin B as a marker of spermatogenesis. J. Clin. Endocrinol. Metab. 1998, 83(9):3110.
25. Pierik F.H., Burdorf A., De Jong F.H., Weber R.F. Inhibin B a novel marker of spermatogenesis. Ann. Med. 2003, 35(1):12.
26. Robertson D.M., Foulds L.M., Leversha L., Morgan F.J., Hearn M.T., Burger H.G., Wettenhall R.E., de Kretser D.M. Isolation of Inhibin from bovine follicular fluid. Biochem. Biophys. Res. Commun. 1985, 126:220.
27. Robertson D.M., Cahir N., Burger H.G., Mamers P., McCloud P.I., Pettersson K., McGuckin M. Combined inhibin and CA125 assays in the detection of ovarian cancer. Clin. Chem. 1999, 45(5):651.
28. Robertson D.M., Stephenson T., Pruysers E., McCloud P.I., Tsigos A., Groome N.P., Mamers P., Burger H.G. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer. J. Clin. Endocrinol. Metab. 2002, 87(2):816.
29. Robertson D.M., Burger H.G., Fuller P.J. Inhibin/activin and ovarian cancer. Endocrinol. Relat. Cancer. 2004, 11:35.
30. Robertson D.M., Pruysers E., Burger H.G., Jobling T., McNeilage J., Healy D. Inhibins and ovarian cancer. Mol. Cell. Endocrinol. 2004, 255:65.
31. Roudebush W.E., Kivens W.J., Mattke J.M. Biomarkers of ovarian reserve. Biomarker Insights 2008, 3:259.
32. Seifer D.B., Scott R.T., Bergh P.A., Abrogast L.K., Friedman C.I., Mack C.K., Danforth D.R. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Fertil. Steril. 1999, 72(1):63.
33. Urbancsek J., Hauzman E., Klinga K., Rabe T., Papp Z., Strowitzki T. Use of serum Inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome. Fertil. Steril. 2005, 83(2):341.